Combination Chemotherapy for Influenza

Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe

(2017) A Lackenby et al.   Eurosurveillance

Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single Administration

(2010) S. Kubo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection

(2010) N. Sugaya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Natural Viral Load Profile of Patients With Pandemic 2009 Influenza A(H1N1) and the Effect of Oseltamivir Treatment

(2010) Iris W. Li et al.   CHEST

Effects of Early Oseltamivir Therapy on Viral Shedding in 2009 Pandemic Influenza A (H1N1) Virus Infection

(2010) Li M. Ling et al.   CLINICAL INFECTIOUS DISEASES

Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro

(2010) Jack T. Nguyen et al.   PLoS One

Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses

(2010) Maki Kiso et al.   PLoS Pathogens

Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro

(2009) J. T. Nguyen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on Influenza A (H5N1) Virus Infections in Cell Culture and in Mice

(2009) D. F. Smee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice

(2009) D. F. Smee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa

(2009) Aeron C. Hurt et al.   ANTIVIRAL RESEARCH

Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States

(2009) Nila J. Dharan   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pharmacokinetics and Tolerability of Oseltamivir Combined with Probenecid

(2008) M. Holodniy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice

(2008) N. A. Ilyushina et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol

(2008) N. M. Bouvier et al.   JOURNAL OF VIROLOGY

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

(2008) B.-J. Zheng et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Medical Management of Influenza Infection

(2007) Anne Moscona   Annual Review of Medicine

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance

(2007) Olivier Ferraris et al.   JOURNAL OF CLINICAL VIROLOGY